Diversity in Clinical Trials: Why It Matters and How We Can Do Better

CSRS Team
Jul 15, 2025
5 min read

Clinical research moves medicine forward, yet many trials still overlook the very communities they aim to serve. Diversity in clinical trials is more than a buzz phrase - it is the backbone of fair, reliable science.

Throughout this blog, we will discuss why representation counts, where current efforts fall short, and how researchers, mentors, and sponsors can fix the gap.

Why Diverse Clinical Trial Participation Matters

Every person’s body reacts to treatment differently. Yet over 80% of U.S. clinical trial participants are white, despite the fact that chronic illnesses disproportionately affect communities of color.

When trials lack representation, we get skewed results - and risky surprises later on.

Diversity in clinical trials improves safety by showing how medications work across a broad range of people. It also builds public trust, especially in communities that have historically been left out or mistreated.

In fact, trials with a diverse participant pool are more likely to succeed after launch. Patients are more willing to take part when they see someone like them involved in the process.

Drug companies benefit too, with fewer post-marketing side effects and better compliance.

Still, achieving diversity is not as simple as just “recruiting more people.” We first need to understand the systems and habits holding us back.

Health Equity in Research: Are We There Yet?

We’re making progress - but not fast enough.

Fewer than 10% of participants in U.S. cancer trials are Black, even though Black Americans face the highest cancer mortality rates of any racial group.

Women, elderly adults, and non-English speakers are often underrepresented too. This isn’t just a fairness issue - it directly affects outcomes.

When drugs aren’t tested on a wide range of people, side effects go unnoticed and some groups may not respond well at all.

Health equity means that every person has a fair chance at the best care. That includes access to trials, support during participation, and results that reflect their experience.

The reality is: most trials are still built around what’s convenient for the sponsor, not the participant.

To get closer to equity, research needs to start where people are - in their communities. But as you’ll see next, several roadblocks are still in the way.

What’s Holding Us Back from Inclusive Trials?

Let’s be honest, location is a huge barrier. Most trials are based in large hospitals, often in cities that are hard to reach without reliable transport. That alone can keep rural, disabled, or low-income participants from even trying.

Language can also get in the way. Consent forms and instructions are typically written in complex English, which can intimidate non-native speakers.

Trust plays a role too. For many people of color, there’s a deep-rooted fear tied to unethical research in the past.

Money matters as well. Missing work, paying for childcare, or covering gas can be dealbreakers for working families. These “hidden costs” make trial participation unrealistic for many.

Clinical Research Organizations (CROs) often default to working with familiar sites and staff. That means they unintentionally overlook smaller clinics that serve diverse communities.

According to a 2022 Tufts study, only 15% of U.S. trial sites track diversity data in real time.

Without tracking, it’s nearly impossible to adjust or improve mid-study.

Diversity readiness in clinical research requires more than a DEI checkbox. It’s about real infrastructure - budgeting interpreters, bias training, and support staff.

This is where mentorship and guidance can help research teams do better. But what does “doing better” look like? Let’s explore some solutions.

Strategies to Improve Diversity in Clinical Trials

Want to run a more inclusive trial? Start with these practice shifts:

Inclusive Trial Practices vs Traditional Models

Practice	Traditional Model	Inclusive Model
Site location	Academic hospital	Community clinic + telehealth
Consent forms	English only	Multilingual, plain language
Outreach	Physician referral	Social media + local events
Visit schedule	Weekdays, 9‑5	Evenings, weekends, home visits
Compensation	Travel stipend	Childcare, wage support

Data adapted from CISCRP and Deloitte Insights, 2023

Community partners can be powerful allies in building trust. Involving them early in study design improves communication and buy-in. Likewise, training a more diverse network of investigators can help reach underrepresented patients.

Tech can help too. Decentralized trials, like using home visits or wearable trackers, make participation easier.

According to Deloitte, these approaches can boost recruitment by up to 60%, especially for underserved groups. (Source: Deloitte Insights, 2023)

Real-time dashboards are also key. They help sponsors spot diversity gaps early, so adjustments can be made before it’s too late.

If you’re wondering how to increase diversity in trials, these practical steps are a great start. But first, you need to know if your site is even ready.

Diversity Readiness in Clinical Research: Is Your Site Prepared?

You don’t need to guess – you can start by asking yourself these questions.

Does your staff reflect the population you’re trying to recruit?
Are your materials available in other languages or accessible formats?
Can participants get in and out easily, even on weekends?

NIH offers a simple 0–5 scoring tool to measure how prepared your site is. Scores below 3 usually mean urgent changes are needed in areas like communication or community outreach. Support from mentors can make a big difference here. At Clinical Research Solutions, we help teams identify where they’re falling short - and what to fix first.

Even small shifts, like offering ride-share vouchers or on-site childcare, can drive enrollment up within weeks. Sponsors often see better retention and faster recruitment when basic access barriers are removed. If you’re serious about inclusive trials, it starts with asking the hard questions. Then, it’s time to take action.

Your Role in Building Fair Science

Diversity in clinical trials isn’t optional- it’s the only way to make sure medicine works for all. It strengthens trust, improves safety, and speeds up access to life-saving treatments. Whether you’re a student, coordinator, or sponsor, you have a role to play. That starts with awareness - and continues with action.

Clinical Science Research Solutions is here to support you. We offer real mentorship for research professionals who want to create more inclusive studies, from the ground up. If you're ready to learn what truly inclusive research looks like in practice, we’re ready to help you get there. Let’s build research that reflects the real world- together!